Related Experiment Video
Updated: Jul 18, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Inflammatory Biomarker Profiles in Very Preterm Infants within the Context of Preeclampsia, Chorioamnionitis, and
Jordan T Ewald1, Baiba Steinbrekera2, Jennifer R Bermick3
1Roy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA.
Insights
Inflammatory biomarkers like MCP-1 and CRP reveal distinct patterns in preterm infants based on prenatal factors such as preeclampsia or infection. Postnatal infections also show unique biomarker signatures, aiding in early detection.
Area of Science:
- Neonatal immunology
- Biomarker discovery
- Infectious disease in neonates
Background:
- Preterm infants face increased infection risk, but inflammatory biomarker ontogeny is poorly understood.
- Prenatal factors like preeclampsia and infection, and postnatal infections, influence infant health.
- Understanding these biomarker patterns is crucial for managing preterm infants.
Purpose of the Study:
- To investigate unique inflammatory biomarker signatures in extremely preterm infants.
- To determine associations between prenatal factors (preeclampsia, chorioamnionitis) and postnatal infections with biomarker profiles.
- To assess the influence of prematurity on these biomarker patterns.
Main Methods:
- Collected daily and weekly blood samples from 142 neonates (22-32 weeks gestation) for the first 14 weeks.
- Measured monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) using a custom array.
- Obtained C-reactive protein (CRP) levels from electronic medical records.
Main Results:
- Maternal preeclampsia was linked to increased MCP-1, independent of gestational age.
- Chorioamnionitis with funisitis showed decreased MCP-1 and increased CRP.
- Postnatal infections elevated IL-6 and CRP, with distinct peak times.
Conclusions:
- Prenatal and postnatal infections, along with pregnancy complications, create unique inflammatory biomarker profiles in preterm infants.
- Biomarker patterns are largely independent of gestational age.
- IL-6 elevation precedes CRP in postnatal infections, suggesting potential for targeted screening if antibiotics are withheld.
Abstract:
Preterm delivery can be precipitated by preeclampsia or infection, and preterm infants are at heightened risk of postnatal infection. Little is known about the ontogeny of inflammatory biomarkers in extremely preterm infants. We hypothesized that suspected prenatal infection (clinical chorioamnionitis or spontaneous preterm labor) and clinically diagnosed postnatal infection would be associated with unique biomarker signatures, and those patterns would be influenced by the degree of prematurity. Venous blood was collected daily for the first week and weekly for up to 14 additional weeks from 142 neonates born at 22-32 weeks gestation. A custom array was utilized to measure monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6). C-reactive protein (CRP) levels were obtained from the electronic medical record. Independent of gestational age, MCP-1 was significantly increased (p < 0.001) in association with maternal preeclampsia, but MCP-1 was decreased (p < 0.01), and CRP was increased (p < 0.01) in the presence of chorioamnionitis with funisitis. IL-6 and CRP were both increased in infants diagnosed with postnatal infection, with peak levels observed on days 2 and 3, respectively. In conclusion, suspected prenatal and postnatal infections and non-infectious complications of pregnancy are associated with unique biomarker profiles, independent of gestational age, including over a 2-fold increase in MCP-1 among newborns of mothers with preeclampsia. Further, in those clinically diagnosed with a postnatal infection in the absence of antenatal infection concerns, IL-6 increases before CRP, emphasizing a potential role for expanded biomarker screening if antibiotics are initially avoided in infants delivered for maternal indications.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017